Adam Mizel is Director at PACIFICHEALTH LABORATORIES INC (PHLI). They have made 7 open-market trades across 3 companies since 2007, most recently 2013-03-21.
CIK 0001079310
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $140K since 2007, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CIDM | SELL | 2012-11-28 | 2012-11-30 | $1.58 | $60K | -7.5% | +1.1% | +1.1% |
| CIDM | BUY | 2012-11-28 | 2012-11-30 | $1.58 | $60K | -7.5% | +1.1% | +1.1% |
| PHLI | BUY | 2009-09-04 | 2009-09-10 | $0.25 | $2K | N/A | N/A | N/A |
| PHLI | BUY | 2007-12-04 | 2007-12-06 | $0.72 | $11K | N/A | N/A | N/A |
| PHILI | BUY | 2007-11-30 | 2007-12-04 | $0.83 | $42K | N/A | N/A | N/A |
| PHLI | BUY | 2007-08-16 | 2007-08-20 | $2.21 | $8K | N/A | N/A | N/A |
| PHLI | BUY | 2007-08-13 | 2007-08-15 | $2.30 | $18K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.